Alpha 2.0
Login Register
» Authors » Matthew Stanton

Matthew Stanton

Explore the profile of Matthew Stanton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 153
Followers 0
Related Specialties
Toxicology
Pharmacology
Health Services
Top 10 Co-Authors
Ryan Feldman
David Gummin
Maulin Patel
Jillian Theobald
Amro Alsaid
Cathyyen Dang
Osama Mahmoud
Rajesh Kuppuraju
Hadi Mahmaljy
Edwin Hernandez Campoverde
Published In
Clin Toxicol (Phila)
J Med Toxicol
Telemed J E Health
Shock
J Emerg Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Utility of iron concentration two to four hours post ingestion in predicting toxicity
Fox H, Jansen A, Theobald J, Stanton M, Feldman R
Am J Emerg Med . 2024 Nov; 87:70-73. PMID: 39509998
Introduction: Iron products are widely available over the counter and have the potential to cause serious toxicity. Iron concentrations can be used to prognosticate and guide treatment during acute ingestions....
2.
Reader Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM
Feldman R, Theobald J, Stanton M, Stolbach A, Tormoehlen L
Neurology . 2024 Apr; 102(9):e209363. PMID: 38648601
No abstract available.
3.
(blue Indonesian pit viper) envenomation treated with Thai green pit viper antivenom
Feldman R, Stanton M, Corcoran J, Bialkowski K, Theobald J, Gummin D
Clin Toxicol (Phila) . 2024 Mar; 62(3):207-209. PMID: 38525877
No abstract available.
4.
A Case of Severe Lead Encephalopathy with Cardiac Arrest Managed During a Chelation Shortage
Idowu D, Gray Z, Stanton M, Rushton W, Gummin D
J Med Toxicol . 2023 Oct; 20(1):49-53. PMID: 37843802
Introduction: For many years, the standard of care in the USA has been to treat acute lead encephalopathy with a combination parenteral dimercaprol (BAL) and CaNaEDTA. We present a case...
5.
Lack of Association of Initial Vasopressor Dosing with Survival and Cardiac Re-Arrest Likelihood After Return of Spontaneous Circulation
Sharpe A, Richardson K, Stanton M, Dang C, Feih J, Brazauskas R, et al.
J Emerg Med . 2023 Aug; 65(3):e209-e220. PMID: 37635036
Background: Cardiac arrest occurs in approximately 350,000 patients outside the hospital and approximately 30,000 patients in the emergency department (ED) annually in the United States. When return of spontaneous circulation...
6.
Incidence of rebound salicylate toxicity following cessation of urine alkalinization
OKeefe M, Stanton M, Feldman R, Theobald J
Clin Toxicol (Phila) . 2023 Jul; 61(7):536-542. PMID: 37427892
Introduction: Management of patients with salicylate toxicity frequently requires urine alkalinization to enhance excretion of salicylate. One strategy for determining when to stop urine alkalinization is to wait for two...
7.
Excess baggage in describing acetylcysteine regimens
Stanton M, Feldman R, Gummin D
Clin Toxicol (Phila) . 2022 Dec; 61(1):88-89. PMID: 36484497
No abstract available.
8.
Hemodialysis enhances elimination of ethosuximide in massive overdose
Wells L, Stanton M, Gummin D, Brooks M, Feldman R
Clin Toxicol (Phila) . 2022 Jul; 60(9):1078-1079. PMID: 35894638
No abstract available.
9.
Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage
Cicci C, Weiss A, Dang C, Stanton M, Feldman R
Pharmacotherapy . 2022 Apr; 42(5):366-374. PMID: 35384000
Study Objective: The objective of this study was to evaluate clinical outcomes associated with time to administration and dose of four-factor prothrombin complex concentrate (4F-PCC) in patients with ICH on...
10.
Supratherapeutic digoxin concentrations after second trimester termination of pregnancy
Stanton M, Mellesmoen J, Gummin D
Clin Toxicol (Phila) . 2022 Feb; 60(6):778-779. PMID: 35132934
No abstract available.